Juan Eduardo Robledo Almonacid, Christian Lombardo, Mariana Romano, Agustina Quiroga, Paula Cambuli Bianchi, Mauricio Hualpa, Constanza Giai, Xiomara María A Oviedo, Ramiro Alejo Salgado Mansur, Mariana Guadalupe Vallejo, Cristián Andrés Quintero
{"title":"世卫组织的关键细菌清单:在实施和开发基于人工智能的监测工具八年后的科学反应。","authors":"Juan Eduardo Robledo Almonacid, Christian Lombardo, Mariana Romano, Agustina Quiroga, Paula Cambuli Bianchi, Mauricio Hualpa, Constanza Giai, Xiomara María A Oviedo, Ramiro Alejo Salgado Mansur, Mariana Guadalupe Vallejo, Cristián Andrés Quintero","doi":"10.3389/fphar.2025.1633382","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In 2017, the World Health Organization (WHO) issued a global alert identifying 12 bacteria in urgent need of new treatments.</p><p><strong>Main body: </strong>This study assesses the scientific community's response to this alert by analyzing original research publications using LLMzCor, an AI-based tool developed and validated by our group. To compare trends, we focused on publications from 5 years before and after the alert, specifically on three bacteria listed in the WHO alert, sorted by priority level: <i>Acinetobacter baumannii</i> (Critical), <i>Shigella</i> spp (High), and <i>Neisseria gonorrhoeae</i> (Medium) and three non-listed as controls (<i>Rickettsia</i> spp., <i>C. trachomatis</i>, and <i>C. difficile)</i>. Articles were classified into three categories: (i) identification of Resistant strains, (ii) development of New treatments, and (iii) Immunization strategies.</p><p><strong>Results: </strong>Although overall publications increased after the WHO alert, no statistically significant changes were found in the reports of Resistant strains over time. The development of New treatments for the listed bacteria showed a slight increase, between 2% and 10%. Furthermore, Immunization strategies remained relatively unchanged, with less than 2%. Meanwhile, LLMzCor demonstrated robust performance across categories, F1-scores ranging from 0.65 to 0.72 in key classifications, while recall peaked at 0.75, indicating a high capacity to identify relevant articles. These results support the model's reliability for large-scale automated classification of scientific abstracts.</p><p><strong>Conclusion: </strong>These findings, supported by LLMzCor, underscore the urgency of a stronger WHO alert and action plans to develop new strategies against bacterial resistance.</p>","PeriodicalId":12491,"journal":{"name":"Frontiers in Pharmacology","volume":"16 ","pages":"1633382"},"PeriodicalIF":4.8000,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12461225/pdf/","citationCount":"0","resultStr":"{\"title\":\"The WHO's critical bacteria list: scientific response eight years after its implementation and development of an AI-based tool for its monitoring.\",\"authors\":\"Juan Eduardo Robledo Almonacid, Christian Lombardo, Mariana Romano, Agustina Quiroga, Paula Cambuli Bianchi, Mauricio Hualpa, Constanza Giai, Xiomara María A Oviedo, Ramiro Alejo Salgado Mansur, Mariana Guadalupe Vallejo, Cristián Andrés Quintero\",\"doi\":\"10.3389/fphar.2025.1633382\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>In 2017, the World Health Organization (WHO) issued a global alert identifying 12 bacteria in urgent need of new treatments.</p><p><strong>Main body: </strong>This study assesses the scientific community's response to this alert by analyzing original research publications using LLMzCor, an AI-based tool developed and validated by our group. To compare trends, we focused on publications from 5 years before and after the alert, specifically on three bacteria listed in the WHO alert, sorted by priority level: <i>Acinetobacter baumannii</i> (Critical), <i>Shigella</i> spp (High), and <i>Neisseria gonorrhoeae</i> (Medium) and three non-listed as controls (<i>Rickettsia</i> spp., <i>C. trachomatis</i>, and <i>C. difficile)</i>. Articles were classified into three categories: (i) identification of Resistant strains, (ii) development of New treatments, and (iii) Immunization strategies.</p><p><strong>Results: </strong>Although overall publications increased after the WHO alert, no statistically significant changes were found in the reports of Resistant strains over time. The development of New treatments for the listed bacteria showed a slight increase, between 2% and 10%. Furthermore, Immunization strategies remained relatively unchanged, with less than 2%. Meanwhile, LLMzCor demonstrated robust performance across categories, F1-scores ranging from 0.65 to 0.72 in key classifications, while recall peaked at 0.75, indicating a high capacity to identify relevant articles. These results support the model's reliability for large-scale automated classification of scientific abstracts.</p><p><strong>Conclusion: </strong>These findings, supported by LLMzCor, underscore the urgency of a stronger WHO alert and action plans to develop new strategies against bacterial resistance.</p>\",\"PeriodicalId\":12491,\"journal\":{\"name\":\"Frontiers in Pharmacology\",\"volume\":\"16 \",\"pages\":\"1633382\"},\"PeriodicalIF\":4.8000,\"publicationDate\":\"2025-09-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12461225/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Pharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3389/fphar.2025.1633382\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fphar.2025.1633382","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
The WHO's critical bacteria list: scientific response eight years after its implementation and development of an AI-based tool for its monitoring.
Background: In 2017, the World Health Organization (WHO) issued a global alert identifying 12 bacteria in urgent need of new treatments.
Main body: This study assesses the scientific community's response to this alert by analyzing original research publications using LLMzCor, an AI-based tool developed and validated by our group. To compare trends, we focused on publications from 5 years before and after the alert, specifically on three bacteria listed in the WHO alert, sorted by priority level: Acinetobacter baumannii (Critical), Shigella spp (High), and Neisseria gonorrhoeae (Medium) and three non-listed as controls (Rickettsia spp., C. trachomatis, and C. difficile). Articles were classified into three categories: (i) identification of Resistant strains, (ii) development of New treatments, and (iii) Immunization strategies.
Results: Although overall publications increased after the WHO alert, no statistically significant changes were found in the reports of Resistant strains over time. The development of New treatments for the listed bacteria showed a slight increase, between 2% and 10%. Furthermore, Immunization strategies remained relatively unchanged, with less than 2%. Meanwhile, LLMzCor demonstrated robust performance across categories, F1-scores ranging from 0.65 to 0.72 in key classifications, while recall peaked at 0.75, indicating a high capacity to identify relevant articles. These results support the model's reliability for large-scale automated classification of scientific abstracts.
Conclusion: These findings, supported by LLMzCor, underscore the urgency of a stronger WHO alert and action plans to develop new strategies against bacterial resistance.
期刊介绍:
Frontiers in Pharmacology is a leading journal in its field, publishing rigorously peer-reviewed research across disciplines, including basic and clinical pharmacology, medicinal chemistry, pharmacy and toxicology. Field Chief Editor Heike Wulff at UC Davis is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.